Latest News about AZN
Recent news which mentions AZN
Why AstraZeneca Stock Is Trading Higher Tuesday
February 20, 2024
From Benzinga
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
From InvestorPlace
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
From InvestorPlace
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
February 13, 2024
From InvestorPlace
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
February 13, 2024
From Motley Fool
This Analyst Slightly Lowers AstraZeneca Forecast Amid Earnings Concerns, Although Still Bullish on Future Growth Potential
February 12, 2024
From Benzinga
From Slack To Surveillance: Here's How Companies Monitor Your Communications With AI
February 10, 2024
From Benzinga
From Motley Fool
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
February 08, 2024
Tickers
AZN
From Motley Fool
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 08, 2024
From Benzinga
AstraZeneca Stock Tumbles After Q4 Performance - Here's Why
February 08, 2024
From Benzinga
Earnings Scheduled For February 8, 2024
February 08, 2024
From Benzinga
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
From InvestorPlace
History Says the Nasdaq Will Keep Soaring in 2024. Here's the Surprising Megacap Stock Wall Street Thinks Will Be the Biggest Winner.
February 03, 2024
Tickers
AZN
From Motley Fool
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
From Benzinga
3 No-Brainer Stocks to Buy With $500 Right Now
January 31, 2024
From Motley Fool
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
From Benzinga
3 Magnificent Stocks to Buy and Hold Forever
January 27, 2024
From Motley Fool
From Benzinga
AstraZeneca Tries To Reach New Ground For Its Lead Cancer Drug Imfinzi With New Data In Liver Cancer Study
January 19, 2024
From Benzinga
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
January 15, 2024
From InvestorPlace
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
From Benzinga
Oxford University Kicks off Human Study for AstraZeneca's COVID-19 Vaccine Technology in Nipah Virus Defense
January 11, 2024
From Benzinga
Evaluating AstraZeneca Against Peers In Pharmaceuticals Industry
January 09, 2024
From Benzinga
4 Superior Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 06, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.